Peter Rowe

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from Peter C. Rowe)
Jump to: navigation, search
Source: Dr. Peter Rowe's website

Peter C. Rowe, MD, has been the director of the Johns Hopkins Children's Center Chronic Fatigue Clinic in Baltimore, Maryland, US, since 1996. He serves as a professor of Pediatrics at the Johns Hopkins University School of Medicine.[1] In 2007, he became the inaugural recipient of the Sunshine Natural Wellbeing Foundation Chair in Chronic Fatigue and Related Disorders at Johns Hopkins University.[2]

As a leader in the field of pediatric myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Dr Rowe is invited as a frequent guest at ME/CFS conferences and served as one of the experts on the "Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome" that was convened for the 2015 Institute of Medicine report.[3] He, also, serves on the Solve ME/CFS Initiative Research Advisory Council.[4]

He lists his fields of expertise as: Adolescent Medicine, Chronic Fatigue Syndrome (CFS), Fibromyalgia (FMS), General Pediatrics, Orthostatic Intolerance (OI), Pediatrics and his research interests as: CFS; FMS; Ehlers-Danlos Syndrome (EDS) ; OI; Gulf War Illness (GWS); and Pelvic congestion syndrome.[1]

Awards[edit | edit source]

Clinic Location[edit | edit source]

Johns Hopkins Pediatrics
Appointment Phone: 410-955-9229
200 N. Wolfe Street
Rubenstein Child Health Building
Baltimore, MD 21287
For information on requesting an appointment.

Committees[edit | edit source]

2017 Pediatric Primer[edit | edit source]

Dr. Rowe was one of the authors of the 2017 Pediatric Primer published in Frontiers in Pediatrics.

ME/CFS Common Data Element (CDE) Project[edit | edit source]

Chair of the Autonomic Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke (NNDS) and the Centers for Disease Control & Prevention (CDC)[7]

Medscape Continuing Medicine Education[edit | edit source]

Notable studies[edit | edit source]

  • 1995, The relationship between neurally mediated hypotension and the chronic fatigue syndrome[9] -(Abstract)
  • 1997, Comparison of heart rate variability in patients with chronic fatigue syndrome and controls[10] - (Abstract)
  • 1998, Neurally mediated hypotension and chronic fatigue syndrome[11] - (Abstract)
  • 1999, Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome[12] - (Abstract)
  • 2003, Cerebral and systemic hemodynamics changes during upright tilt in chronic fatigue syndrome[13] - (Abstract)
  • 2007, Successful use of a primary care practice-specialty collaboration in the care of an adolescent with chronic fatigue syndrome[14] - (Abstract)
  • 2013, Neuromuscular strain as a contributor to cognitive and other symptoms in chronic fatigue syndrome: hypothesis and conceptual model[15] - (Full Text)
  • 2013, What is brain fog? An evaluation of the symptom in postural tachycardia syndrome[16] - (Full Text)
  • 2014, Impaired range of motion of limbs and spine in chronic fatigue syndrome[17] - (Abstract)
  • 2014, Disease mechanisms and clonidine treatment in adolescent chronic fatigue syndrome: a combined cross-sectional and randomized clinical trial[18] - (Full Text)
  • 2016, Neuromuscular Strain Increases Symptom Intensity in Chronic Fatigue Syndrome[19] - (Full Text)
  • 2016, Cow's milk protein intolerance in adolescents and young adults with chronic fatigue syndrome[20] - (Abstract)
  • 2018, Two-Year Follow-Up of Impaired Range of Motion in Chronic Fatigue Syndrome[21] - (Full text)
  • 2018, Improvement of severe myalgic encephalomyelitis/chronic fatigue syndrome symptoms following surgical treatment of cervical spinal stenosis[22] - (Full Text)
  • 2018, Two-Year Follow-Up of Impaired Range of Motion in Chronic Fatigue Syndrome[21] - (Full text)
  • 2018, Blood Volume Status in ME/CFS Correlates With the Presence or Absence of Orthostatic Symptoms: Preliminary Results[23] - (Full text)
  • 2018, Low Sensitivity of Abbreviated Tilt Table Testing for Diagnosing Postural Tachycardia Syndrome in Adults With ME/CFS[24]
  • 2019, Impaired health-related quality of life in adolescent myalgic encephalomyelitis/chronic fatigue syndrome: the impact of core symptoms[25] - (Full text)
  • 2019, Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning[26] - (Full text)
  • 2020, Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography[27] - (Full text)

Webinars[edit | edit source]

Part 1 - Written questions and answers to Dr. Rowe's webinar
Part 2 - Written questions and answers to Dr. Rowe's webinar
Part 3 - Written questions and answers to Dr. Rowe's webinar
Part 4 - Written questions and answers to Dr. Rowe's webinar

Talks and interviews[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

  • 05/21/2017 - Pediatrician Peter Rowe’s Relentless Energy For Treating Patients with Chronic Fatigue by Karen Blum for Johns Hopkins Medicine newsletter[30]

Reference[edit | edit source]

  1. 1.01.1 "Peter C Rowe, M.D., Professor of Pediatrics". Johns Hopkins Medicine. Retrieved Oct 11, 2019. 
  2. 2.02.1 Donor, Office of; Baltimore, Volunteer Engagement 3400 North Charles Street; Development, MD 21218 410-516-8490; Relations, Alumni. "Sunshine Natural Wellbeing Foundation Professorship in Chronic Fatigue Syndrome and Related Disorders". Named Deanships, Directorships, and Professorships. Retrieved Mar 25, 2019. 
  3. Syndrome, Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue; Populations, Board on the Health of Select; Medicine, Institute of (Feb 10, 2015). Biographical Sketches of Committee Members, Consultants, and Staff. National Academies Press (US). 
  4. "Research Advisory Council". Solve ME/CFS Initiative. Retrieved Oct 11, 2019. 
  5. "IACFS/ME Awardees". IACFS/ME. Retrieved Apr 23, 2020. 
  6. Rowe, Peter C.; Underhill, Rosemary A.; Friedman, Kenneth J.; Gurwitt, Alan; Medow, Marvin S.; Schwartz, Malcolm S.; Speight, Nigel; Stewart, Julian M.; Vallings, Rosamund; Rowe, Katherine S. (2017), "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer", Frontiers in Pediatrics, 5 (121), doi:10.3389/fped.2017.00121 
  7. "Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster". NIH. Retrieved Oct 11, 2019. 
  8. Corbin, Lisa; Komaroff, Anthony L.; Natelson Peter C. Rowe, Benjamin H.; Rowe, Peter. "A Case-Based Approach to Chronic Fatigue Syndrome". Medscape. Retrieved Oct 11, 2019. 
  9. Bou-Holaigah, Issam; Rowe, Peter C.; Kan, Jean; Calkins, Hugh (Sep 27, 1995). "The Relationship Between Neurally Mediated Hypotension and the Chronic Fatigue Syndrome". JAMA: The Journal of the American Medical Association. 274 (12): 961. doi:10.1001/jama.1995.03530120053041. ISSN 0098-7484. 
  10. Yataco, A.; Talo, H.; Rowe, P.; Kass, D. A.; Berger, R. D.; Calkins, H. (Dec 1997). "Comparison of heart rate variability in patients with chronic fatigue syndrome and controls". Clinical Autonomic Research: Official Journal of the Clinical Autonomic Research Society. 7 (6): 293–297. ISSN 0959-9851. PMID 9430800. 
  11. Rowe, PC; Calkins, H (1998), "Neurally mediated hypotension and chronic fatigue syndrome", Am J Med, 105 (3A): 15S-21S, PMID 9790477 
  12. Rowe, PC; Barron, DF; Calkins, H; Maumenee, IH; Tong, PY; Geraghty, MT (1999), "Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome", J Pediatr, 135 (4): 494-9, PMID 10518084 
  13. Razumovsky, AY; DeBusk, K; Calkins, H; Snader, S; Lucas, KE; Vyas, P; Hanley, DF; Rowe, PC (2003), "Cerebral and systemic hemodynamics changes during upright tilt in chronic fatigue syndrome", J Neuroimaging, 13 (1): 57-67, PMID 12593133 
  14. Kuo, DZ; Cheng, TL; Rowe, PC (2007), "Successful use of a primary care practice-specialty collaboration in the care of an adolescent with chronic fatigue syndrome", Pediatrics, 120 (6): e1536-9, doi:10.1542/peds.2007-0493, PMID 18055669 
  15. Rowe, P. C.; Fontaine, K. R.; Violand, R. L. (2013), "Neuromuscular strain as a contributor to cognitive and other symptoms in chronic fatigue syndrome: hypothesis and conceptual model", Frontiers in Physiology, 4 (115), doi:10.3389/fphys.2013.00115 
  16. Ross, A. J.; Medow, M. S.; Rowe, P. C.; Stewart, J. M. (2013), "What is brain fog? An evaluation of the symptom in postural tachycardia syndrome.", Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society, 23 (6): 305–311, doi:10.1007/s10286-013-0212-z 
  17. Rowe, PC; Marden, CL; Flaherty, MA; Jasion, SE; Cranston, EM; Johns, AS; Fan, J; Fontaine, KR; Violand, RL (2014), "Impaired range of motion of limbs and spine in chronic fatigue syndrome", J Pediatr, 165 (2): 360-6, doi:10.1016/j.jpeds.2014.04.051 
  18. Sulheim, D; Fagermoen, E; Winger, A; Andersen, AM; Godang, K; Müller, F; Rowe, PC; Saul, JP; Skovlund, E; Øie, MG; Wyller, VB (2014), "Disease mechanisms and clonidine treatment in adolescent chronic fatigue syndrome: a combined cross-sectional and randomized clinical trial", JAMA Pediatrics, 168 (4): 351-60, doi:10.1001/jamapediatrics.2013.4647, PMID 24493300 
  19. Rowe, PC; Fontaine, KR; Lauver, M; Jasion, SE; Marden, CL; Moni, M; Thompson, CB; Violand, RL (Jul 18, 2016), "Neuromuscular Strain Increases Symptom Intensity in Chronic Fatigue Syndrome", PLOS One, doi:10.1371/journal.pone.0159386, PMID 27428358 
  20. Rowe, Peter C; Marden, Colleen L; Jasion, Samantha E; Cranston, Erica M; Flaherty, Marissa A; Kelly, Kevin J (Jun 3, 2016), "Cow's milk protein intolerance in adolescents and young adults with chronic fatigue syndrome", Acta Paediatrica, 105 (9): e412–e418, doi:10.1111/apa.13476, PMID 27177188 
  21. 21.021.1 Rowe, Peter C.; Marden, Colleen L.; Flaherty, Marissa A.K.; Jasion, Samantha E.; Cranston, Erica M; Fontaine, Kevin R.; Violand, Richard L. (2018), "Two-Year Follow-Up of Impaired Range of Motion in Chronic Fatigue Syndrome", The Journal of Pediatrics, doi:10.1016/j.jpeds.2018.05.012 
  22. Rowe, Peter C.; Marden, Colleen L.; Heinlein, Scott; Edwards II, Charles C. (2018), "Improvement of severe myalgic encephalomyelitis/chronic fatigue syndrome symptoms following surgical treatment of cervical spinal stenosis", Journal of Translational Medicine, 16 (21), doi:10.1186/s12967-018-1397-7 
  23. Visser, Frans C.; Rowe, Peter C.; van Campen, C. (Linda) M. C. (2018). "Blood Volume Status in ME/CFS Correlates With the Presence or Absence of Orthostatic Symptoms: Preliminary Results". Frontiers in Pediatrics. 6. doi:10.3389/fped.2018.00352. ISSN 2296-2360. PMID 30525014. 
  24. Visser, Frans C.; Rowe, Peter C.; van Campen, C. (Linda) M. C. (2018). "Low Sensitivity of Abbreviated Tilt Table Testing for Diagnosing Postural Tachycardia Syndrome in Adults With ME/CFS". Frontiers in Pediatrics. 6. doi:10.3389/fped.2018.00349. ISSN 2296-2360. PMID 30505831. 
  25. Roma, Maria; Marden, Colleen L.; Flaherty, Marissa; Jasion, Samantha E.; Cranston, Erica M.; Rowe, Peter C. (Jan 22, 2019). "Impaired health-related quality of life in adolescent myalgic encephalomyelitis/chronic fatigue syndrome: the impact of core symptoms". Frontiers in Pediatrics. doi:10.3389/fped.2019.00026. 
  26. Proskauer, Charmian; Rowe, Peter C.; Lapp, Charles W.; DeMaria, Alfred Jr; Bateman, Lucinda; Attewell, John R.; Proskauer, Daniel; Kiernicki, David J.; Adebayo, Seyi (2019). "Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning". Frontiers in Pediatrics. 6. doi:10.3389/fped.2018.00412. ISSN 2296-2360. PMID 30671425. 
  27. van Campen, C. (Linda) M.C.; Verheugt, Freek W.A.; Rowe, Peter C.; Visser, Frans C. (Feb 8, 2020). "Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography". Clinical Neurophysiology Practice. 5: 50–58. doi:10.1016/j.cnp.2020.01.003. PMC 7044650Freely accessible. PMID 32140630. 
  28. https://en.wikipedia.org/wiki/I_Remember_Me
  29. "ME/CFS Canadian Collaborative Team Conference program" (PDF). Retrieved Mar 6, 2019. 
  30. "Pediatrician Peter Rowe's Relentless Energy For Treating Patients with Chronic Fatigue". www.hopkinsmedicine.org. Retrieved Mar 25, 2019. 

ME/CFS - An acronym that combines myalgic encephalomyelitis with chronic fatigue syndrome. Sometimes they are combined because people have trouble distinguishing one from the other. Sometimes they are combined because people see them as synonyms of each other.

myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

chronic fatigue syndrome (CFS) - A fatigue-based illness. The term CFS was invented invented by the U.S. Centers for Disease Control as an replacement for myalgic encephalomyelitis (ME). Some view CFS as a neurological disease, others use the term for any unexplained long-term fatigue. Sometimes used as a the term as a synonym of myalgic encephalomyelitis, despite the different diagnostic criteria.

chronic fatigue syndrome (CFS) - A fatigue-based illness. The term CFS was invented invented by the U.S. Centers for Disease Control as an replacement for myalgic encephalomyelitis (ME). Some view CFS as a neurological disease, others use the term for any unexplained long-term fatigue. Sometimes used as a the term as a synonym of myalgic encephalomyelitis, despite the different diagnostic criteria.

orthostatic intolerance (OI) - The development of symptoms when standing upright, where symptoms are relieved upon reclining. Patients with orthostatic intolerance have trouble remaining upright for more than a few seconds or a few minutes, depending upon severity. In severe orthostatic intolerance, patients may not be able to sit upright in bed. Orthostatic intolerance is often a sign of dysautonomia. There are different types of orthostatic intolerance, including postural orthostatic tachycardia syndrome (POTS).

Centers for Disease Control and Prevention (CDC) - The Centers for Disease Control and Prevention is a U.S. government agency dedicated to epidemiology and public health. It operates under the auspices of the Department of Health and Human Services.

chronic fatigue syndrome (CFS) - A fatigue-based illness. The term CFS was invented invented by the U.S. Centers for Disease Control as an replacement for myalgic encephalomyelitis (ME). Some view CFS as a neurological disease, others use the term for any unexplained long-term fatigue. Sometimes used as a the term as a synonym of myalgic encephalomyelitis, despite the different diagnostic criteria.

heart rate variability (HRV) - A measurement of the variability of the heart rate over time. When the heart rate is consistent, there will be a low heart rate variability. When the heart rate is constantly changing, there will be a high heart rate variability. Heart rate variability is often used by ME/CFS patients to monitor their autonomic nervous system, as high heart rate variability is associated with the sympathetic nervous system and low heart rate variability is associated with the parasympathetic nervous system.

myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

tachycardia - An unusually rapid heart beat. Can be caused by exercise or illness. A symptom of postural orthostatic tachycardia syndrome (POTS). (Learn more: www.heart.org)

orthostatic intolerance (OI) - The development of symptoms when standing upright, where symptoms are relieved upon reclining. Patients with orthostatic intolerance have trouble remaining upright for more than a few seconds or a few minutes, depending upon severity. In severe orthostatic intolerance, patients may not be able to sit upright in bed. Orthostatic intolerance is often a sign of dysautonomia. There are different types of orthostatic intolerance, including postural orthostatic tachycardia syndrome (POTS).

myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

National Institutes of Health (NIH) - A set of biomedical research institutes operated by the U.S. government, under the auspices of the Department of Health and Human Services.

orthostatic intolerance (OI) - The development of symptoms when standing upright, where symptoms are relieved upon reclining. Patients with orthostatic intolerance have trouble remaining upright for more than a few seconds or a few minutes, depending upon severity. In severe orthostatic intolerance, patients may not be able to sit upright in bed. Orthostatic intolerance is often a sign of dysautonomia. There are different types of orthostatic intolerance, including postural orthostatic tachycardia syndrome (POTS).

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.